Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

BACKGROUND: Patients with the metabolic syndrome are more likely to develop type 2 diabetes and may have an increased risk of cardiovascular disease (CVD) events.We aimed to establish whether CVD event rates were influenced by the metabolic syndrome as defined by the World Health Organisation (WHO),...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Scott, Russell, Donoghoe, Mark, Watts, Gerald F, O'Brien, Richard, Pardy, Christopher, Taskinen, Marja-Riitta, Davis, Timothy ME, Colman, Peter G, Manning, Patrick, Fulcher, Gregory, Keech, Anthony C
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2011
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286386/
https://ncbi.nlm.nih.gov/pubmed/22104275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-10-102
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars